Why EU Must Reform Regulation And Funding For Life-Saving Cancer Biomarker Tests

 
• By Eliza Slawther

UK and EU patients have inadequate and inconsistent access to cancer biomarker tests, which experts warn is hindering the use of life-saving targeted medicines. Could parallel regulatory and reimbursement processes for drugs and diagnostics provide a solution?

Cancer tumor biomarker test
• Source: Shutterstock

More from Europe

More from Geography